Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Caprolactam ChemicalsBOM:507486 55 EBITDA Margin % is 54.15% as of Mar. 2026, which is 56% above its 10-year median of 34.79. GuruFocus rates BOM:507486 with a GF Score™ of 55/100 and a GF Value™ of ₹72.25 (Possible Value Trap). The stock has 3 warning signs investors should review. Among 1,578 Chemicals companies, Caprolactam Chemicals ranks better than 97.53% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Caprolactam Chemicals EBITDA Margin % Related Terms
Caprolactam Chemicals EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Caprolactam Chemicals's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Caprolactam Chemicals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Caprolactam Chemicals EBITDA Margin % vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Caprolactam Chemicals's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Caprolactam Chemicals's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Caprolactam Chemicals (BOM:507486) has a EBITDA Margin % of 54.15% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Caprolactam Chemicals and its competitors. This is 56% above median its historical median of 34.79. According to the industry distribution chart, Caprolactam Chemicals ranks #39 out of 1578 companies in the Chemicals industry, placing it in the top 2.5%.
Is Caprolactam Chemicals' EBITDA Margin % too high?
Caprolactam Chemicals' current EBITDA Margin % of 54.15% is 56% above median its 10-year median of 34.79. The Chemicals industry median EBITDA Margin % is 9.64. Caprolactam Chemicals' value of 54.15% is 461.7% above this industry median. Based on the distribution chart, Caprolactam Chemicals ranks #39 out of 1578 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Caprolactam Chemicals has a GF Score™ of 55/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Caprolactam Chemicals' EBITDA Margin % compare to DOW?
According to the Chemicals industry distribution chart, Caprolactam Chemicals ranks #39 out of 1578 companies for EBITDA Margin %. This places Caprolactam Chemicals in the top 3% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 9.64. Caprolactam Chemicals' value of 54.15% is 461.7% above this benchmark. While the company's 10-year median is 34.79 vs. the industry median of 9.64, Caprolactam Chemicals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Chemicals company?
The median EBITDA Margin % among Chemicals companies is 9.64, based on 1,578 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Caprolactam Chemicals's current EBITDA Margin % of 54.15% is 461.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Caprolactam Chemicals and its competitors. For the Chemicals industry, the median EBITDA Margin % is 9.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Caprolactam Chemicals's current EBITDA Margin % is 54.15%, which is 56% above median its own 10-year median of 34.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Caprolactam Chemicals stock overvalued right now?
Based on GuruFocus' analysis, Caprolactam Chemicals (BOM:507486) is currently considered Possible Value Trap. The stock's GF Value™ is ₹72.25, compared to a current price of ₹49.84 — trading 31% below its estimated fair value. The current EBITDA Margin % is 54.15%, which is 56% above median its 10-year median of 34.79 and 461.7% above the Chemicals industry median of 9.64. Caprolactam Chemicals' overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Caprolactam Chemicals (BOM:507486), the current EBITDA Margin % is 54.15% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Caprolactam Chemicals (BOM:507486) Overvalued in 2026?
Based on GuruFocus' analysis, Caprolactam Chemicals stock appears to be undervalued.
The current stock price of ₹49.84 is trading 31% below its estimated GF Value™ of ₹72.25.
GuruFocus considers Caprolactam Chemicals to be Possible Value Trap.
Key valuation signals for BOM:507486:
EBITDA Margin %: 54.15% (56% above median its 10-year median of 34.79)
GF Value™: ₹72.25 vs. price of ₹49.84 (31% below fair value)
Industry Position: 461.7% above the Chemicals median (#39 of 1578)
No single metric tells the full story. See the BOM:507486 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Caprolactam Chemicals Ltd is an Indian company which is engaged in manufacturing of chemicals and provides Job work services as per customers requirements.
55GF Score
Get the complete analysis for BOM:507486
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:507486 has been successfully added to your 
